Chemours (CC) Capital Expenditures (2014 - 2026)

Chemours has reported Capital Expenditures for 13 years, with the latest figure at $44.0 million in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 2.33% year-over-year to $44.0 million in Q2 2026; TTM through Jun 2026 was $179.0 million, a 42.63% decrease from a year earlier, with the FY2025 full-year figure at $213.0 million, down 40.83% from the prior year.
• Capital Expenditures was $44.0 million for Q2 2026 at Chemours, down from $49.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $135.0 million in Q4 2023, with the low at $41.0 million in Q3 2025.
• Average Capital Expenditures over 5 years is $74.6 million, with a median of $72.5 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Capital Expenditures surged 101.49% in 2023, then slumped 58.72% in 2025.
• Over 5 years, Capital Expenditures stood at $67.0 million in 2022, then soared by 101.49% to $135.0 million in 2023, then retreated by 19.26% to $109.0 million in 2024, then plunged by 58.72% to $45.0 million in 2025, then retreated by 2.22% to $44.0 million in 2026.
• The last three Capital Expenditures figures came in at $44.0 million (Q2 2026), $49.0 million (Q1 2026), and $45.0 million (Q4 2025), per Business Quant data.